Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503607 · ClinicalTrials.gov registry record · Phase 3
BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
A Phase 3 study of Colonoscopy, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
- 11
- Study locations
NCT00503607 is a Phase 3 study of Colonoscopy that has completed, run by Braintree Laboratories. The registered enrollment target is 400 participants, below the 482-participant average among 20 other Colonoscopy trials with a reported enrollment target (17% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT00503607, a Phase 3 study of Colonoscopy, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
- 11
- Study locations
Study Summary
This is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
Conditions Studied
Interventions
- DRUG BLI-800
- DRUG Polyethylene glycol 3350 based bowel preparation
Study Locations (11)
Florida
- - Jupiter
- - Miami
- - New Smyrna Beach
Alabama
- - Mobile
District of Columbia
- - Washington D.C.
Louisiana
- - Monroe
Maryland
- - Laurel
New York
- - Great Neck
North Carolina
- - Raleigh
Pennsylvania
- - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2007-07 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00503607
The ClinicalTrials.gov registry entry for NCT00503607 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 20 other Colonoscopy trials with a reported enrollment target (17% lower). The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which BLI-800 is the first listed.
NCT00503607 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Florida, Alabama, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00503607 about?
NCT00503607 is a clinical study titled "BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". This is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
What is the current status of trial NCT00503607?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2007-07. Estimated completion is 2007-11.
What conditions does trial NCT00503607 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT00503607?
The interventions under investigation include: BLI-800 (DRUG), Polyethylene glycol 3350 based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT00503607?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00503607 being conducted?
This trial has 11 study locations across Alabama, District of Columbia, Florida, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
-
HalfLytely Bowel Prep System for Colonoscopy
COMPLETED · Phase 3
-
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
COMPLETED · Phase 3
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.